Ishani Malhotra is the Chief Executive Officer and founder of Carcinotech, a medtech company with expertise in manufacturing 3D printed living tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells. Shas eight years’ experience in oncology and stem cell research with degrees and was recently recognised as one of the 35 rising stars by Scottish Business Insider under 35, won AccelerateHER 2022 awards for Science and MedTech and won the Female Entrepreneur of the Year award at The Scottish SME Business Awards 2022. She has established significant international partnerships to advance Carcinotech’s vision of providing personalised drug testing platforms to help those suffering from cancer. Ishani holds a Bachelor of Engineering (B.E.) degree in Biotechnology from PES University, Bangalore, India and a Master of Science (MSc) degree in Regenerative Medicine from The University of Edinburgh and a Certificate of Achievement in cancer genetics from Harvard Medical School.